Sfoglia per AUTORE
PROCOPIO G
Collezione AO Ordine Mauriziano

  

Items : 20

Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2025 Feb;23(1):102267. doi: 10.1016/j.clgc.2024.102267. Epub 2024 Nov 10.

2025
ASL Cuneo 2
AO Ordine Mauriziano

Puglisi S; Lipari H; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Spada M; Caffo O; Napoli MD; Atzori F; Malgeri A; Prati V; Sorarù M; Tudini M; Mollica V; Ricotta R; Baldessari C; Fratino L; Merler S; Procopio G; Naglieri E; Masini C; Zucali PA; Galli L; Sbrana A; Chiellino S; De Giorgi U; Maruzzo M; et alii...

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Jul 2;73(9):161. doi: 10.1007/s00262-024-03741-2.

2024
AO Ordine Mauriziano

Messina C; Catalano M; Roviello G; Gandini A; Maruzzo M; De Giorgi U; Pedrazzoli P; Sbrana A; Zucal PA; Masini C; Naglieri E; Procopio G; Milella M; Catalano F; Fratino L; Pipitone S; Ricotta R; Panni S; Mollica V; Soraru M; Prati V; Atzori F; Di Napoli M; Messina M; Morelli F; Prati G; Nole F; Malgeri A; Tudini M; et alii...

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study. in Frontiers in oncology / Front Oncol. 2024 Feb 12;14:1307635. doi: 10.3389/fonc.2024.1307635. eCollection 2024.

2024
ASL Cuneo 2
AO Ordine Mauriziano

Roviello G; Lipari H; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Spada M; Caffo O; Di Napoli M; Atzori F; Malgeri A; Prati V; Sorarù M; Tudini M; Mollica V; Ricotta R; Baldessari C; Fratino L; Milella M; Procopio G; Naglieri E; Masini C; Zucali PA; Galli L; Chiellino S; Bimbatti D; De Giorgi U; Rebuzzi SE; et alii...

Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab. in JAMA network open / JAMA Netw Open. 2023 Nov 1;6(11):e2345185. doi: 10.1001/jamanetworkopen.2023.45185.

2023
AO Ordine Mauriziano

Catalano M; Rebuzzi SE; Maruzzo M; De Giorgi U; Buti S; Galli L; Fornarini G; Zucali PA; Procopio G; Chiellino S; Milella M; Catalano F; Pipitone S; Ricotta R; Sorarù M; Mollica V; Tudini M; Fratino L; Prati V; Caffo O; Atzori F; Morelli F; Prati G; Nolè F; Vignani F; Cavo A; Di Napoli M; Malgeri A; Naglieri E; et alii...

Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial. in European urology / Eur Urol. 2023 Jan;83(1):82-89. doi: 10.1016/j.eururo.2022.09.025. Epub 2022 Oct 8.

2023
AO Ordine Mauriziano

Procopio G; Lolli C; Di Napoli M; Pignata S; Ignazzi G; Gamba T; Veccia A; Scandurra G; Hamzaj A; Ermacora P; Masini C; Aieta M; Atzori F; Stellato M; Carella C; Bimbatti D; Giannatempo P; De Giorgi U; Vignani F; Tambaro R; Pierantoni F; Zonno A; Santini D; Di Maio M;

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study. in Journal of translational medicine / J Transl Med. 2022 Sep 30;20(1):435. doi: 10.1186/s12967-022-03601-6.

2022
ASL Cuneo 2
AO Ordine Mauriziano

Messina M; Caffo O; Di Napoli M; Atzori F; Santini D; Soto Parra HJ; Prati V; Cortellini A; Santoni M; Sorarù M; Mollica V; Panni S; Ricotta R; Pipitone S; Fratino L; Boccardo F; Milella M; Procopio G; Naglieri E; Fantinel E; Zucali PA; Galli L; Chiellino S; Basso U; De Giorgi U; Maruzzo M; Damassi A; Fornarini G; Gandini A; et alii...

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Procopio G; Verzoni E; De Braud FG; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Buttigliero C; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Santini D; Casadei C; Buti S; De Giorgi U; Mennitto A; Zattarin E; Di Maio M; Bimbatti D;

Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group). in Immunotherapy / Immunotherapy. 2022 Feb;14(2):107-114. doi: 10.2217/imt-2021-0109. Epub 2021 Nov 17.

2022
AO Ordine Mauriziano

Procopio G; Losanno T; Naglieri E; Stellato M; Tambaro R; Banna GL; Vignani F; De Giorgi U; Basso U; Maruzzo M; Farè E; Raggi D; Giannatempo P; Mazzaschi G; Bersanelli M; Pignata S; Necchi A; Buti S;

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The ?-Meet-URO analysis. in Frontiers in oncology / Front Oncol. 2022 Sep 23;12:955501. doi: 10.3389/fonc.2022.955501. eCollection 2022.

2022
ASL Cuneo 2
AO Ordine Mauriziano

Nolè F; Prati G; Morelli F; Messina M; Caffo O; Di Napoli M; Atzori F; Soto Parra HJ; Prati V; Cortellini A; Sorarù M; Santoni M; Massari F; Panni S; Ricotta R; Sabbatini R; Fratino L; Boccardo F; Milella M; Procopio G; Carella C; Fantinel E; Zucali PA; Galli L; Pedrazzoli P; De Giorgi U; Maruzzo M; Santini D; Stellato M; et alii...

Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7). in American journal of clinical oncology / Am J Clin Oncol. 2021 Mar 1;44(3):121-125. doi: 10.1097/COC.0000000000000791.

2021
AO Ordine Mauriziano

Mini E; Grillone F; Mucciarini C; Fornarini G; Soraru' M; Verzoni E; Sbrana A; Di Lorenzo G; De Vivo R; Bersanelli M; Buti S; Naglieri E; Bimbatti D; Maruzzo M; Casadei C; De Lisi D; Pantano F; De Giorgi U; Stellato M; Santini D; Vignani F; Attademo L; Pignata S; Procopio G;

Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b). in Frontiers in oncology / Front Oncol. 2021 Jun 8;11:682449. doi: 10.3389/fonc.2021.682449. eCollection 2021.

2021
AO Ordine Mauriziano

Mucciarini C; Vignani F; De Vivo R; Napolitano A; Buti S; Naglieri E; Di Lorenzo G; Soraru M; Sbrana A; Maruzzo M; Fornarini G; Casadei C; Pantano F; De Giorgi U; Verzoni E; Santini D; Stellato M; Grillone F; Roviello G; Di Napoli M; Procopio G;

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 May 18;13:17588359211019642. doi: 10.1177/17588359211019642. eCollection 20

2021
AO Ordine Mauriziano

Bersanelli M; Casadei C; Pierantoni F; Roviello G; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Messina C; Messina M; Pignata S; Atzori F; Stellato M; Soto Parra HJ; Prati V; Santoni M; Cortellini A; Sorarù M; Mollica V; Panni S; Ricotta R; Baldessari C; Fratino L; Tomasello L; Merler S; Procopio G; Naglieri E; Masini C; et alii...

Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study). in American journal of clinical oncology / Am J Clin Oncol. 2020 Sep;43(9):621-627. doi: 10.1097/COC.0000000000000719.

2020
AO Ordine Mauriziano

Sepe P; Martinetti A; Mennitto A; Verzoni E; Claps M; Raimondi A; Sottotetti E; Grassi P; Guadalupi V; Stellato M; Zattarin E; Di Maio M; Procopio G;

Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion. in ESMO open / ESMO Open. 2020 Mar;5(2):e000652. doi: 10.1136/esmoopen-2019-000652.

2020
AO Ordine Mauriziano

Santini D; Berruti A; Di Maio M; Procopio G; Bracarda S; Ibrahim T; Bertoldo F;

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study. in Immunotherapy / Immunotherapy. 2020 Feb;12(2):151-159. doi: 10.2217/imt-2019-0180.

2020
AO Ordine Mauriziano

Bersanelli M; Buti S; Banna GL; De Giorgi U; Cortellini A; Rebuzzi SE; Tiseo M; Fornarini G; Mazzoni F; Panni S; De Tursi M; Di Marino P; Rossetti S; Rossi E; Tomao S; De Luca E; Sorarù M; Mucciarini C; Atzori F; La Torre L; Vitale MG; Martelli V; Sepe P; Mollica V; Vaccaro V; Schinzari G; Ficorella C; Massari F; Maestri A; et alii...

Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic. in Frontiers in oncology / Front Oncol. 2020 Apr 30;10:648. doi: 10.3389/fonc.2020.00648. eCollection 2020.

2020
AO Ordine Mauriziano

Fratino L; Procopio G; Di Maio M; Cinieri S; Leo S; Beretta G;

Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2019 Feb;17(1):e150-e155. doi: 10.1016/j.clgc.2018.10.001. Epub 2018 Oct 10.

2019
AO Ordine Mauriziano

Masini C; Vitale MG; Maruzzo M; Procopio G; de Giorgi U; Buti S; Rossetti S; Iacovelli R; Atzori F; Cosmai L; Vignani F; Prati G; Scagliarini S; Guida A; Berselli A; Pinto C;

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. in Immunotherapy / Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080.

2018
AO Ordine Mauriziano

Bersanelli M; Giannarelli D; Castrignanò P; Fornarini G; Panni S; Mazzoni F; Tiseo M; Rossetti S; Gambale E; Rossi E; Papa A; Cortellini A; Lolli C; Ratta R; Michiara M; Milella M; De Luca E; Sorarù M; Mucciarini C; Atzori F; Banna GL; La Torre L; Vitale MG; Massari F; Rebuzzi SE; Facchini G; Schinzari G; Tomao S; Bui S; et alii...

Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2018 Aug;16(4):e735-e742. doi: 10.1016/j.clgc.2018.01.016. Epub 2018 Feb 5.

2018
AO Ordine Mauriziano

Ratta R; Verzoni E; Di Maio M; Grassi P; Colecchia M; Fucà G; de Braud F; Procopio G;

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey. in PloS one / PLoS One. 2013 Dec 30;8(12):e83026. doi: 10.1371/journal.pone.0083026. eCollection 2013.

2013
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sabbatini R; Maiello E; Adamo V; Tanca FM; Fedeli SL; Badalamenti G; Russo A; Collovà E; Satolli MA; Silvestris N; Santoni M; Virzì V; Lanzetta G; Carteni G; Ottaviani D; Ortega C; Vincenzi B; Berardi R; Berruti A; Fontana A; Mazzara C; Barni S; Porta C; Ibrahim T; Procopio G; Santini D; Felici A; Cinieri S; Tonini G; et alii...